These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 36509377)

  • 61. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis.
    Daneman N; Sarwar S; Fowler RA; Cuthbertson BH;
    Lancet Infect Dis; 2013 Apr; 13(4):328-41. PubMed ID: 23352693
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A pandemic within a pandemic? Admission to COVID-19 wards in hospitals is associated with increased prevalence of antimicrobial resistance in two African settings.
    Elton L; Abdel Hamid MM; Tembo J; Elbadawi H; Maluzi K; Abdelraheem MH; Cullip T; Kabanda C; Roulston K; Honeyborne I; Thomason MJ; Elhag K; Mohammed A; Adam A; Mulonga K; Sikakena K; Matibula P; Kabaso M; Nakazwe R; Fwoloshi S; Zumla A; McHugh TD
    Ann Clin Microbiol Antimicrob; 2023 Apr; 22(1):25. PubMed ID: 37055793
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016.
    Mao T; Zhai H; Duan G; Yang H
    Pol J Microbiol; 2019; 68(2):225-232. PubMed ID: 31250593
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Trend analysis of carbapenem-resistant Gram-negative bacteria and antimicrobial consumption in the post-COVID-19 era: an extra challenge for healthcare institutions.
    de Carvalho Hessel Dias VM; Tuon F; de Jesus Capelo P; Telles JP; Fortaleza CMCB; Pellegrino Baena C
    J Hosp Infect; 2022 Feb; 120():43-47. PubMed ID: 34808311
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Carbapenemase-Encoding Genes and Colistin Resistance in Gram-Negative Bacteria During the COVID-19 Pandemic in Mexico: Results from the Invifar Network.
    Garza-Ramos U; Silva-Sánchez J; López-Jácome LE; Hernández-Durán M; Colín-Castro CA; Sánchez-Pérez A; Rodríguez-Santiago J; Morfín-Otero R; Rodriguez-Noriega E; Velázquez-Acosta MD; Vázquez-Larios MDR; Feliciano-Guzmán JM; Rojas-Larios F; Ponce-De-Leon A; Lozano-Garcia M; Choy-Chang EV; López-Gutiérrez E; Molina-Jaimes A; Gil-Veloz M; Corte-Rojas RE; López-Ovilla I; Ramirez-Mis JL; Rodríguez-Balderas DE; Molina-Chavarria A; Padilla-Ibarra C; Quevedo-Ramos MA; Mireles-Dávalos CD; Rodríguez-Medina N; Rubio-Mendoza D; Córdova-Fletes C; Cruz-López F; Becerra-Montejano DA; Mercado-Longoria R; Martínez-Villarreal RT; Barlandas-Rendón NRE; Mena-Ramírez JP; Couoh-May CA; Alcaraz-Espejel M; Adame-Alvarez C; Hernández-Vicente L; Garza-González E
    Microb Drug Resist; 2023 Jun; 29(6):239-248. PubMed ID: 36595348
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Risk perception of the antimicrobial resistance by infection control specialists in Europe: a case-vignette study.
    Birgand G; Mutters NT; Ahmad R; Tacconelli E; Lucet JC; Holmes A;
    Antimicrob Resist Infect Control; 2020 Feb; 9(1):33. PubMed ID: 32059746
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Emergence of carbapenem resistant gram-negative pathogens with high rate of colistin resistance in Egypt: A cross sectional study to assess resistance trends during the COVID-19 pandemic.
    Afify FA; Shata AH; Aboelnaga N; Osama D; Elsayed SW; Saif NA; Mouftah SF; Shawky SM; Mohamed AA; Loay O; Elhadidy M
    J Genet Eng Biotechnol; 2024 Mar; 22(1):100351. PubMed ID: 38494251
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antimicrobial use and resistance data in human and animal sectors in the Lao PDR: evidence to inform policy.
    Chansamouth V; Mayxay M; Dance DA; Roberts T; Phetsouvanh R; Vannachone B; Vongsouvath M; Davong V; Inthavong P; Khounsy S; Keohavong B; Keoluangkhot V; Choumlivong K; Day NP; Turner P; Ashley EA; van Doorn HR; Newton PN
    BMJ Glob Health; 2021 Nov; 6(12):. PubMed ID: 34853032
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Emerging Antimicrobial Resistance.
    Flynn CE; Guarner J
    Mod Pathol; 2023 Sep; 36(9):100249. PubMed ID: 37353202
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of antimicrobial stewardship managed by clinical pharmacists on antibiotic use and drug resistance in a Chinese hospital, 2010-2016: a retrospective observational study.
    Wang H; Wang H; Yu X; Zhou H; Li B; Chen G; Ye Z; Wang Y; Cui X; Zheng Y; Zhao R; Yang H; Wang Z; Wang P; Yang C; Liu L
    BMJ Open; 2019 Aug; 9(8):e026072. PubMed ID: 31377693
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The challenges of multi-drug-resistance in hepatology.
    Fernández J; Bert F; Nicolas-Chanoine MH
    J Hepatol; 2016 Nov; 65(5):1043-1054. PubMed ID: 27544545
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [The Change in Antimicrobial Resistance During the COVID-19 Pandemic in Türkiye].
    Yılmaz N; Altınkanat Gelmez G; Söyletir G;
    Mikrobiyol Bul; 2023 Oct; 57(4):507-534. PubMed ID: 37885383
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of Bi-Lateral Co-Infections and Antibiotic Resistance Rates among COVID-19 Patients in Lahore, Pakistan.
    Rizvi A; Saeed MU; Nadeem A; Yaqoob A; Rabaan AA; Bakhrebah MA; Al Mutair A; Alhumaid S; Aljeldah M; Al Shammari BR; Albayat H; Alwashmi ASS; Nainu F; Alhashem YN; Naveed M; Ahmed N
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888623
    [No Abstract]   [Full Text] [Related]  

  • 74. The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis.
    Antimicrobial Resistance Collaborators
    Lancet Glob Health; 2024 Feb; 12(2):e201-e216. PubMed ID: 38134946
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.
    Tomczyk S; Taylor A; Brown A; de Kraker MEA; El-Saed A; Alshamrani M; Hendriksen RS; Jacob M; Löfmark S; Perovic O; Shetty N; Sievert D; Smith R; Stelling J; Thakur S; Vietor AC; Eckmanns T;
    J Antimicrob Chemother; 2021 Oct; 76(11):3045-3058. PubMed ID: 34473285
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The real-world impact of the BioFire FilmArray blood culture identification 2 panel on antimicrobial stewardship among patients with bloodstream infections in intensive care units with a high burden of drug-resistant pathogens.
    Chen HY; Tseng HY; Chen CL; Lin YC; Liang SJ; Tu CY; Chen WC; Hsueh PR
    J Microbiol Immunol Infect; 2024 Aug; 57(4):580-593. PubMed ID: 38942661
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antimicrobial resistance among GLASS priority pathogens from Pakistan: 2006-2018.
    Saeed DK; Farooqi J; Shakoor S; Hasan R
    BMC Infect Dis; 2021 Dec; 21(1):1231. PubMed ID: 34876041
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antimicrobial use and antimicrobial resistance trends in Canada: 2014.
    Ebrahim M; Gravel D; Thabet C; Abdesselam K; Paramalingam S; Hyson C
    Can Commun Dis Rep; 2016 Nov; 42(11):227-231. PubMed ID: 29769991
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interventions to improve antibiotic prescribing practices for hospital inpatients.
    Davey P; Brown E; Charani E; Fenelon L; Gould IM; Holmes A; Ramsay CR; Wiffen PJ; Wilcox M
    Cochrane Database Syst Rev; 2013 Apr; (4):CD003543. PubMed ID: 23633313
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prevalence of Colonization With Antibiotic-Resistant Organisms in Hospitalized and Community Individuals in Bangladesh, a Phenotypic Analysis: Findings From the Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
    Chowdhury F; Mah-E-Muneer S; Bollinger S; Sharma A; Ahmed D; Hossain K; Hassan MZ; Rahman M; Vanderende D; Sen D; Mozumder P; Khan AA; Sarker M; Smith RM; Styczynski A; Luvsansharav UO
    Clin Infect Dis; 2023 Jul; 77(Suppl 1):S118-S124. PubMed ID: 37406054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.